期刊文献+

阿魏酸钠对兔急性心肌梗死再灌注后无复流的影响 被引量:5

Effect of sodium ferulate on no-reflow in a rabbit model of acute myocardial infarction and reperfusion
下载PDF
导出
摘要 目的探讨阿魏酸钠对兔急性心肌梗死(acute myocardial infarction,AMI)再灌注后无复流的作用及机制。方法随机将24只成熟雄性新西兰大白兔分为假手术组、对照组、阿魏酸钠组3组,每组8只,分别建立AMI缺血再灌注模型,于缺血前5min、结扎后240 min,再灌注后120 min取静脉血。采用酶联免疫吸附法(ELISA)测定血清白介素-6(IL-6);免疫组织化学法观察心肌组织P-选择素(Ps)的变化;应用硫黄素染色评估无复流面积。结果①对照组和阿魏酸钠组AMI后240 min、再灌注后120 min的血清IL-6均显著高于假手术组(P均<0.01);阿魏酸钠组各时间点除AMI前血清IL-6均显著低于对照组(P均<0.05)。②Ps免疫组化显示,对照组及阿魏酸钠组中,Ps在复流区及无复流区血管内皮细胞有强表达,明显强于正常区及假手术组(P均<0.01);阿魏酸钠组与对照组比较,Ps在复流区及无复流区表达均明显减弱(P均<0.01)。③病理染色分析示,阿魏酸钠组结扎区心肌范围与对照组相比差异无统计学意义(P均>0.05);无复流区心肌范围与对照组相比显著降低(P均<0.01)。结论阿魏酸钠能有效抑制炎症反应,防治AMI再灌注后无复流。 Objective To evaluate effects of sodium ferulate on no-reflow phenomenon in a rabbit model of acute myocardial infarction and reperfusion. Methods Twenty-four mature male rabbits were randomly divided into sham-operated group, control group, sodium ferulate group with 8 in each group. The later groups were subjected to 240 minutes of left circumflex coronary artery (LCX) occlusion followed by 120 minutes of reperfusion. The serum levels of IL-6 were measured by ELISA ;To observe myocardial P-seleetin (Ps) by immunohistoehemical (IHC) method. The area of no-reflow was evaluated with pathological means. Results ①Compared with the sham-operated group, IL-6 in blood sample in control group and sodium ferulate group, increased significantly at the end of 240 rain of LCX occlusion and 120 min of reperfusion ( all P 〈0. 01 ) ; In each time point but before AMI IL-6 in blood in sodium ferulate group was lower significantly than that in control group ( all P 〈 0.05 ). ② In control and sodium ferulate groups, it was showed by IHC that P-selectin powerfully expressed in vascular endothelial cell of reflow and no-reflow myocardium, and more powerfully than normal myocardium and sham-operated groups ( all P 〈 0. 01 ) ;In sodium ferulate group, its expression in reflow and no-fellow myocardium attenuated significantly than that in control group( all P 〈 0. 01 ). ③Between sodium ferulate group and control group, there was no significant diference in coronary ligation area ( P 〉 0. 05 ) ; The area of no-reflow of sodium ferulate group , decreased significantly compared with control group ( P 〈 0.01 ). Conclusion Sodium ferulate is effective in antiinflammation and preventing myocardial no-reflow in rabbit with acute myocardial infarction and reperfusion.
出处 《滨州医学院学报》 2009年第2期103-105,共3页 Journal of Binzhou Medical University
关键词 阿魏酸钠 炎症 白介素-6 P-选择素 无复流 sodium ferulate, inflammation, interleukin-6, P-selectin, no-reflow
  • 相关文献

参考文献8

  • 1Kloner RA, Rude RE, Carlson N, et al. Uhrastructural evidence of microvascular damage and myocardial cell injury after coronary occlusion[J]. Circulation, 1980, 62(5) : 945-952.
  • 2Ross R. Atherosclerosis - an inflammatory disease [ J ]. N Engl J Med, 1999, 3d0(2) :115-126.
  • 3Helmy SA, Wahby MA, El-Nawaway M. The effect of anaesthesia and surgery on plasma cytokine production[J]. Anaesthesia, 1999, 54(8) :733-738.
  • 4喻东亮,詹锋,徐建军,周琼.阿魏酸钠对体外循环肺保护作用的研究[J].中华胸心血管外科杂志,2005,21(4):241-243. 被引量:7
  • 5Herrmann J. Peri-procedural myocardial injury : 2005 update [ J ]. Eur Heart J,2005,26:2493-519.
  • 6杨跃进,赵京林,孟亮,田毅,荆志成,吴永建,尤士杰,杨伟宪,陈纪林,高润林,陈在嘉.中药通心络(超微粉碎)对猪急性心肌梗死再灌注后无再流的影响[J].中国中西医结合杂志,2006,26(1):49-53. 被引量:33
  • 7Taylor A J , Bobik A , Richards M , et al. Myocardial endothelin-1 release and indices of inflammation during angioplasty for acute myocardial infarction and stable coronary artery disease [ J ]. Am Heart J, 2004,148(2) :10-13.
  • 8傅颖君,何明.阿魏酸钠对心肌细胞缺氧/复氧损伤的保护作用及其机制[J].药学学报,2004,39(5):325-327. 被引量:23

二级参考文献24

  • 1赵明中,高承梅,张宇洋.通心络胶囊对实验性心肌缺血再灌注损伤保护作用的实验研究[J].中国中医基础医学杂志,2000,6(1):36-38. 被引量:50
  • 2黄建邦,刘雪芬,陈树元.川芎嗪对人血多形核白细胞呼吸暴发与氧自由基的抑制作用[J].中国中西医结合杂志,1994,14(10):607-609. 被引量:39
  • 3Ito H,Maruyama A,Iwakura K,et al.Clinical implications of the ‘no-reflow' phenomenon:a predictor of complications and left ventricular remodeling in perfused anterior wall myocardial infarction.Circulation 1996; 93:223-228.
  • 4Gersh BJ.Optimal management of acute myocardial infarction at the down of the next millennium.Am Heart J 1999; 138 (2Pt2):188-202.
  • 5Piana RN,Paik GY,Moscucci M,et al.Incidence and treat ment of "no-reflow" after percutaneous coronary intervention.1994;89:2514.
  • 6Ito H,Tomooka T,Sakai N,et al.Lack of myocardial perfusion immediately after successful thrombolysis:a predictor of poor recovery of left ventricular function in anterior myocardial infarction.Circulation 1992; 85:1699-1705.
  • 7Abbo KM,Dooris M,Glaziar S.Features and outcome of noreflow after percutaneous coronary intervention.Am J Cardiol 1995 ;75:778-82.
  • 8Morshima J.Long term prognostic impact of angiographic noreflow phenomenon in patients treated with angioplasty for acute myocardial infarction possible involvement of left ventricular remodeling.Circulation 1999; 100(Suppl 1):451-456.
  • 9Eeckhout E,Kern MJ.The coronary no-reflow phenomenon:a review of mechanism and therapies.Eur Heart J 2001; 22:729-739.
  • 10Babbitt DG,Virmani R,Forman MB.Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model.Circulation 1989; 80(5):1388-1399.

共引文献60

同被引文献66

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部